Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409289 · ClinicalTrials.gov registry record
RHAPSody: Diagnostic Utility of RUSH Following ROSC
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 5
- Enrollment target
NCT03409289: Clinical Trial study, sponsored by University of Florida.
NCT03409289 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03409289 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This will be a prospective observational study of adult primary cardiac arrest patients presenting to Shands Emergency Department following ROSC or actively in cardiac arrest with subsequent ROSC after treatment in the emergency department.
Primary Outcome
Assessment of a contributing diagnosis or cause of cardiac arrest following performance of the extended RUSH exam. We will examine if a diagnosis is provided or supported by the RUSH exam and if this leads to intervention.
Interventions
- DEVICE RUSH Exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2020-11-14 |
Why NCT03409289 stopped before completion
NCT03409289 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which RUSH Exam is the first listed.
NCT03409289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03409289 about?
NCT03409289 is a clinical study titled "RHAPSody: Diagnostic Utility of RUSH Following ROSC". This will be a prospective observational study of adult primary cardiac arrest patients presenting to Shands Emergency Department following ROSC or actively in cardiac arrest with subsequent ROSC after treatment in the emergency department.
What is the current status of trial NCT03409289?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2018-05-01. Estimated completion is 2020-11-14.
What interventions are being tested in trial NCT03409289?
The interventions under investigation include: RUSH Exam (DEVICE).
Who is sponsoring clinical trial NCT03409289?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI